Professors

Vangelis G. Manolopoulos

  • Faculty: Clinical Pharmacology and Pharmacogenetics
  • Degrees: Full professor of Pharmacology at: - Medical School of Democritus University of Thrace in Alexandroupolis, Greece - Clinical Pharmacology and Pharmacogenetics Unit of the Academic General Hospital of Evros

Dr Vangelis G. Manolopoulos is a full professor of Pharmacology at the Medical School of Democritus University of Thrace in Alexandroupolis, Greece and also serves at the Clinical Pharmacology and Pharmacogenetics Unit of the Academic General Hospital of Evros.

Ηe did undergraduate studies in biology in Patras University and obtained a PhD from the Medical School of the same Univesrity in 1991. Between Jan 1992 and Aug 1995 he was a postdoctoral researcher at the Milwaukee Clinical Campus of the University of Wisconsin, USA.

His next post was as a research scientist in the department of Physiology of the Medical School of the Catholic University in Leuven, Belgium, between Sep 1995 and Nov 1998. Since Dec 1998 Dr Manolopoulos has been at the Faculty of the Medical School in Thrace teaching basic and clinical pharmacology to medical students.

Also, since 2001 he has developed and teaches a course in Pharmacogenetics, one of the first to be introduced to the Medical School undergraduate curriculum worldwide. His current basic and translational research activities include the clinical applications of pharmacogenomics in drugs used for cardiovascular diseases, diabetes, anticoagulant therapy, asthma, and psychiatric diseases. In a second line of research he has a long-standing interest in endothelial cell physiology and atherosclerosis. He has authored more than 100 indexed publications including one on the pharmacogenetics of anticoagulation in the New England Journal of Medicine as senior corresponding author (NEJM 369:2304, 2013).

His publications have received more than 2500 citations, and his H Index is 28. He was the Principal Investigator for Greece of the European Consortium for the pharmacogenetics of anticoagulation (EU-PACT). He participates in several consortia on pharmacogenetics including the European Pharmacogenetics Implementation Consortium (EU-PIC) and the global Pharmacogenomics in Childhood Asthma (PICA) consortium.

He is the president-elect of the European Society for Pharmacogenomics and Personalised Therapy (ESPT) and also co-chairs its Education and Courses Division which has organized 3 very successful Summer Schools (Ljubljana 2012, Rome 2014, Belgrade 2016). Also, he is the president ofthe Greek Society for Basic and Clinical Pharmacology (GSP) and a regular evaluator of FP7, HORIZON and COST grants. Finally, he is the Associate Editor of the journal Drug Metabolism and Personalized Therapy, the official journal of ESPT.